Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD

PurposeTo examine the association of serum Ism1, a new adipokine that can regulate glucose uptake, with type 2 diabetes (T2D) in a Chinese population. Considering high prevalence of Nonalcoholic Fatty Liver Disease in patients with type 2 diabetes and the regulating role of Ism1 on glucose uptake of...

Full description

Bibliographic Details
Main Authors: Jiajia Wang, Juan Du, Xiaoxu Ge, Wenfang Peng, Xirong Guo, Wenyi Li, Shan Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Endocrinology
Subjects:
Ism1
type 2 diabetes
NAFLD
diabetes-associated NAFLD
adipokine
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.890332/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.890332/full

Similar Items